Read the FFMI Newsletter online: View as Webpage
NOVEMBER 12, 2019
Training & Events
Thursday, November 14
Danto Auditorium
12:00pm - 1:00pm
Innovation Grand Rounds
Refreshments & Poster Session
Innovation Challenge Pitch Event
Thursday, November 21
MTRAC for Life Sciences Funding Gearing Up for Next Round
The Mi-TRAC mid-stage funding RFP recently closed, and FFMI received 20 applications for the 2020 cycle. Applications came from U-M (Medical School, Dental School, LS&A, and Pharmacy), Michigan State University, Grand Valley State University/Spectrum Health, Wayne State University/Henry Ford Health System, and Western Michigan University. Awardees will be announced in January.

Mi-TRAC Awards are part of the MTRAC for Life Sciences Innovation Hub - a statewide program that accelerates the transfer of technologies from Michigan's institutions of higher education to the private sector for commercialization. Mi-TRAC is co-administered with the U-M Office of Technology Transfer and generously supported by the Michigan Economic Development Corporation.
Michigan Economic Development Corporation Wins
´╗┐Award for MTRAC
The Michigan Economic Development Corporation (MEDC) was recently recognized with four awards at the International Economic Development Council annual conference in Indianapolis. The awards highlight Michigan's business climate as one of the most favorable in the Midwest.

One of the awards MEDC received was a Gold Award for the Michigan Translational Research and Commercialization Program (MTRAC) Program. The MEDC generously supports the MTRAC for Life Sciences Innovation Hub at U-M. Congratulations!
Commercialization Education
Empowering Innovators at the Frankel Cardiovascular Center
The Frankel Cardiovascular Center (FCVC) Innovation Program was created to foster a culture of innovation at the FCVC. Designed to empower innovators, the programs are administered by a collaborative team from the FCVC and Fast Forward Medical Innovation (FFMI).

The FCVC Innovation Challenge, taking place on Thursday, November 14, is an annual pitch competition where four to five teams who submitted top ideas impacting cardiovascular care compete for up to $100,000 in funding.

This exciting event is run much like an episode of "Shark Tank," where the teams pitch their idea to the judges. Anyone at the FCVC - faculty, staff, trainees, patients, and families - is eligible to submit ideas and attend the event.
FFMI Offers Drug Discovery and Development Course
First-of-its-Kind Collaboration with the Novartis Institute for BioMedical Research
The Drug Discovery and Development (D3) Course is a two-day exclusive, project-based, and computer-simulated approach to teaching drug discovery and development.

Tuesday, November 19 & Wednesday, November 20
8:00am-5:00pm (each day)
NCRC Building 10
G063/G064 (Day 1) G065 (Day 2)
Seating is Limited!

Early to mid-career faculty or principal investigators will be assigned roles on a project team and tasked with the discovery and development of new medicine. Participants must commit to the full two-day program.
FFMI/FCVC Innovation Academy Now Accepting Applications
The FFMI/FCVC Aikens Innovation Academy is currently accepting applications/inquiries about its Winter 2020 class, which starts in January. The Aikens Innovation Academy is open to FCVC faculty, staff, and trainees with any innovation (clinical value or commercial potential) affecting cardiovascular care.

Along with the ten-week course on innovation concepts and pitch development, the Aikens Innovation Academy provides mentorship and an opportunity for early-stage development funding. Visit the  Aikens Innovation Academy course page to view the syllabus and to enroll.
11th Cohort of FFMI fast PACE Course Wraps Up
FFMI recently ended the 11th cohort of the  FFMI  fast  PACE Course with a competition in which eight of the ten FFMI fastPACE teams from the University of Michigan, Michigan State University, and Wayne State University pitched their projects to the class and a panel of judges. The project teams graduated from the 4-week program that is designed to provide the knowledge and tools needed to navigate the initial process of innovation and commercialization.

The winners were:
1st place: Courtney Townsel and Hannah Floyd - University of Michigan
2nd place: Jennifer Meddings, Jessica Ameling, and Zizhang Zhang - University of Michigan
3rd place: Erik Martinez-Hackert and Monique Floer - Michigan State University
Crowd Favorite: Courtney Townsel and Hannah Floyd - University of Michigan

Congratulations to the winning project teams!
Out & About with FFMI
FFMI participated in a Translational Funding Fair and a Startup Funding Fair prior to the U-M Office of Technology Transfer's annual Celebrate Invention event. The team met with innovators and other ecosystem partners to discuss the groundbreaking funding programs and opportunities we offer, including Mi-TRACMi-Kickstart, the  Michigan Biomedical Venture Fund, the  U-M Therapeutic Innovation Fund, and the  FFMI/FCVC Innovation Programs.
Michelle Larkin, FFMI Director of Commercialization Programs, and Sara Risch, Biomedical Innovation Specialist, attended the Women Who Fund Forum on October 24, sponsored by ACG Detroit Women's Forum and University of Michigan Center for Venture Capital & Private Equity Finance, Ross School of Business. At the event, Michelle hosted a fireside chat with Mina Sooch, CEO & Co-founder of Ocuphire Pharma.
Bulletin Board
Asahi Kasei Pharma Looking to Collaborate on Drug Development
Asahi Kasei Pharma is publicly calling for new proposals related to drug development research as part of its efforts
´╗┐for open innovation, to promote pharmaceutical research and development through enhanced cooperation with universities, research institutes, and enterprises around the world.

Research areas of focus are chronic pain and neurodegenerative disease, autoimmune disease, critical care medicine, bone and/or cartilage disease, muscle-related disease, core technologies for drug discovery.

The application period begins on January 7, 2020 at 5:00am GMT (12:01am EST), and ends at 8:00am GMT (3:00am EST) on February 26, 2020.

Contact Debra Grega for further details.
Our Collaborators
U-M Tech Transfer
To better navigate the complexities of the U-M biomedical research enterprise, visit the Research Project Lifecycle . This interactive tool provides an overview of the resources available to you, not only within the Medical School Office of Research but also across the University of Michigan.
Fast Forward Medical Innovation is part of the Office of Research, where our mission is to foster an environment of innovation and efficiency that serves the U-M Medical School community and supports biomedical science from insight to impact.